Company Filing History:
Years Active: 2017-2023
Title: Eva-Maria Muchitsch: Innovator in Subcutaneous Administration of ADAMTS13
Introduction
Eva-Maria Muchitsch is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of medical innovations, particularly in the administration of ADAMTS13 formulations. With a total of 5 patents to her name, her work has the potential to impact the treatment of diseases associated with ADAMTS13 and VWF dysfunction.
Latest Patents
One of her latest patents focuses on the subcutaneous administration of ADAMTS13. This invention relates to methods of administering ADAMTS13 formulations subcutaneously to treat diseases or conditions associated with ADAMTS13 and VWF dysfunction. The patent provides evidence of the unexpectedly high bioavailability of ADAMTS13 formulations when administered in this manner.
Career Highlights
Throughout her career, Eva-Maria Muchitsch has worked with notable companies such as Baxalta GmbH and Takeda Pharmaceutical Company Limited. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the medical field.
Collaborations
Eva-Maria has collaborated with several professionals in her field, including Alexandra Nathalie Kopic and Barbara Plaimauer. These collaborations have contributed to her success and the advancement of her inventions.
Conclusion
Eva-Maria Muchitsch is a trailblazer in the field of medical innovations, particularly in the administration of ADAMTS13 formulations. Her contributions are paving the way for new treatment options and improving patient outcomes.